tolbutamide has been researched along with Fatty Liver, Nonalcoholic in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although some studies have explored the roles of gut microbiota and host Cyp450s in drug pharmacokinetics, few have explored their effects on pharmacokinetic variability, especially in disease states." | 1.72 | Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug. ( Chen, LJ; Chen, XP; Chen, Y; Guo, J; Liou, YL; Tan, ZR; Xu, Y; Zhang, SX; Zhang, W; Zhou, HH, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J | 1 |
| Xu, Y | 1 |
| Chen, LJ | 1 |
| Zhang, SX | 1 |
| Liou, YL | 1 |
| Chen, XP | 1 |
| Tan, ZR | 1 |
| Zhou, HH | 1 |
| Zhang, W | 1 |
| Chen, Y | 1 |
| Suzuki, S | 1 |
| Sato, Y | 1 |
| Umegaki, K | 1 |
| Chiba, T | 1 |
2 other studies available for tolbutamide and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug.
Topics: Animals; Chlorzoxazone; Gastrointestinal Microbiome; Metoprolol; Mice; Midazolam; Non-alcoholic Fatt | 2022 |
Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver.
Topics: Animals; Cholesterol, Dietary; Cytochrome P-450 Enzyme System; Diet, High-Fat; Disease Models, Anima | 2016 |